Dr. Reddy is rolling out its olopatadine hydrochloride ophthalmic solution 0.2% and 0.1%, the equivalents to Alcon’s Pataday Once Daily Relief and Pataday Twice Daily Relief
Perrigo's diclofenac sodium topical gel 1% is the first store brand abbreviated new drug application to be approved by the Food and Drug Administration
The store brand version aims to tap into the roughly $200 million in sales that IRI data says the branded product pulled in for the 52 weeks ended May 17